Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Harvard Business School
Boehringer Ingelheim
Covington
Baxter
UBS
Queensland Health
Julphar
Fish and Richardson

Generated: October 19, 2018

DrugPatentWatch Database Preview

Casper Pharma Llc Company Profile

« Back to Dashboard

What is the competitive landscape for CASPER PHARMA LLC, and what generic and branded alternatives to CASPER PHARMA LLC drugs are available?

CASPER PHARMA LLC has fourteen approved drugs.



Summary for Casper Pharma Llc
US Patents:0
Tradenames:15
Ingredients:14
NDAs:14

Drugs and US Patents for Casper Pharma Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Casper Pharma Llc THALITONE chlorthalidone TABLET;ORAL 019574-002 Feb 12, 1992 DISCN No No ➤ Sign Up ➤ Sign Up
Casper Pharma Llc PERMAPEN penicillin g benzathine INJECTABLE;INJECTION 060014-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Casper Pharma Llc HELIDAC bismuth subsalicylate; metronidazole; tetracycline hydrochloride TABLET, CHEWABLE, TABLET, CAPSULE;ORAL 050719-001 Aug 15, 1996 DISCN Yes No ➤ Sign Up ➤ Sign Up
Casper Pharma Llc NEOSPORIN bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 050417-001 Approved Prior to Jan 1, 1982 AT RX Yes No ➤ Sign Up ➤ Sign Up
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET;ORAL 010721-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Casper Pharma Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Casper Pharma Llc THALITONE chlorthalidone TABLET;ORAL 019574-001 Dec 20, 1988 4,933,360 ➤ Sign Up
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-002 Approved Prior to Jan 1, 1982 3,624,205 ➤ Sign Up
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-001 Approved Prior to Jan 1, 1982 3,624,205 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for CASPER PHARMA LLC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 1 mg ➤ Subscribe 2009-08-14
➤ Subscribe Tablets 2 mg ➤ Subscribe 2010-10-12
➤ Subscribe Tablets 1.5 mg ➤ Subscribe 2009-05-06
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Julphar
AstraZeneca
Moodys
Deloitte
Medtronic
Fish and Richardson
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.